Cardio Diagnostics Holdings Inc. Company Profile
NASDAQ: CDIOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
1.96-0.04 (-2.00%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cardio Diagnostics at a glance
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector. The company's shares have traded publicly since 2022. At a market capitalization of $5.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001870144, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Cardio Diagnostics Holdings Inc.
- Ticker
- NASDAQ: CDIO
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Headquarters
- United States
- IPO year
- 2022
- Market cap
- $5.80M
- SEC CIK
- 0001870144
Companies similar to Cardio Diagnostics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TRIBTrinity Biotech plc ADR | 6.75 | -5.59% | $5.49M | vs CDIO |
| QCLSQ/C Technologies Inc. | 0.632 | -8.42% | $5.18M | vs CDIO |
| VNRXVolitionRX Limited | 0.226 | -6.96% | $6.79M | vs CDIO |
| VRAXVirax Biolabs Group Limited | 2.11 | +3.94% | $2.84M | vs CDIO |
| BMRABiomerica Inc. | 1.91 | -10.75% | $8.78M | vs CDIO |
| ICCCImmuCell Corporation | 9.69 | -2.81% | $88.01M | vs CDIO |
| IMDXInsight Molecular Diagnostics Inc. | 3.46 | +2.37% | $113.23M | vs CDIO |
| NNNNAnbio Biotechnology Class A | 4.90 | 0.00% | $215.07M | vs CDIO |